# Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

> **NCT07226232** · PHASE3 · NOT_YET_RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 240 (estimated)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT07226232
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2030-12-02
- **Final completion:** 2031-04-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07226232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07226232, "Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07226232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*